{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T18:40:24Z","timestamp":1678560024937},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1990,8,1]],"date-time":"1990-08-01T00:00:00Z","timestamp":649468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1990,8,1]],"date-time":"1990-08-01T00:00:00Z","timestamp":649468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1990,8]]},"DOI":"10.1007\/bf00171836","type":"journal-article","created":{"date-parts":[[2004,8,15]],"date-time":"2004-08-15T04:46:18Z","timestamp":1092545178000},"page":"269-274","source":"Crossref","is-referenced-by-count":1,"title":["Phase I trial of intravenous vinzolidine (LY 104208) given on a biweekly dosing schedule"],"prefix":"10.1007","volume":"8","author":[{"given":"Daniel R.","family":"Budman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willi","family":"Kreis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Behr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Schulman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Lichtman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven L.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lora","family":"Weiselberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. G.","family":"Satterlee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Vinciguerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00171836_CR1","unstructured":"Vinzolidine. An Investigational New Drug Brochure. Eli Lilly Co. 1981, p 92, on file with the FDA"},{"key":"BF00171836_CR2","first-page":"979","volume":"68","author":"DR Budman","year":"1984","unstructured":"Budman DR, Schulman P, Marks M, Vinciguerra V, Weiselberg L, Kreis W, Degnan TJ: Phase I trial of Vinzolidine. Can Treat Rep 68: 979\u2013982, 1984","journal-title":"Can Treat Rep"},{"key":"BF00171836_CR3","first-page":"65","volume":"IV","author":"R Nelson","year":"1984","unstructured":"Nelson R: Vinzolidine \u2014 A new vinca derivative in clinical trials (Abstr), Chemotherapy Foundation Symposium IV, pp 65\u201366, 1984","journal-title":"Chemotherapy Foundation Symposium"},{"key":"BF00171836_CR4","first-page":"643a","volume":"25","author":"JM Koeller","year":"1984","unstructured":"Koeller JM, Trump DL, Witte RS, Davis TE, Nelson RL, Tormey DC, Ramirez G: Phase I trial and pharmacokinetics of Vinzolidine on a daily \u00d7 5 oral schedule (Abstr). Proc Am Assoc Cancer Res 25: 643a, 1984","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF00171836_CR5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF00171590","volume":"2","author":"BJ Takasugi","year":"1984","unstructured":"Takasugi BJ, Robertone AB, Salmon SE, Jones SE, Alberts DS: Five-day schedule of Vinzolidine, an oral vinca alkaloid, in a variety of tumors. Invest New Drugs 2: 387\u2013390, 1984","journal-title":"Invest New Drugs"},{"key":"BF00171836_CR6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/BF00552717","volume":"14","author":"G Sarna","year":"1985","unstructured":"Sarna G, Mitsuyasu R, Figlin R, Ambersley J, Groopman J: Oral Vinzolidine as therapy for Kaposi's sarcoma and carcinomas of lung, breast, and colon\/rectum. Cancer Chemother Pharmacol 14: 12\u201314, 1985","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF00171836_CR7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer 47: 207\u2013214, 1981","journal-title":"Cancer"},{"key":"BF00171836_CR8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/BF00255290","volume":"16","author":"W Kreis","year":"1986","unstructured":"Kreis W, Budman DR, Schulman P, Freeman J, Greist A, Nelson RL, Marks M, Kevill L: Clinical pharmacology of vinzolidine. Cancer Chemother Pharmacol 16: 70\u201374, 1986","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF00171836_CR9","unstructured":"Taylor C, Salmon S, Alberts D, Robertone A, Peng Y: Phase I study of intravenous Vinzolidine (Abstr). Proc Am Soc Clin Oncol 6: 81a, 1987"},{"key":"BF00171836_CR10","first-page":"1325a","volume":"29","author":"MC Bissery","year":"1988","unstructured":"Bissery MC, White K, Polin L, Puzycki D, Zalupski MM: Murine solid tumor activity of Vinzolidine (Abstr). Proc Am Assoc Cancer Res 29:1325a, 1988","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF00171836_CR11","first-page":"858a","volume":"29","author":"W Kreis","year":"1988","unstructured":"Kreis W, Budman DR, Freeman J, Milazzo J, Bergstrom RF, Nelson R: Clinical pharmacology studies with IV administered 3H-Vinzolidine (Abstr). Proc Am Assoc Cancer Res 29:858a, 1988","journal-title":"Proc Am Assoc Cancer Res"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00171836\/fulltext.html","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00171836.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00171836\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00171836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00171836.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T18:13:09Z","timestamp":1678558389000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00171836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,8]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1990,8]]}},"alternative-id":["BF00171836"],"URL":"https:\/\/doi.org\/10.1007\/bf00171836","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,8]]}}}